CELEBRATING
10 Years of Breakthroughs in Organoid Technology
Over the past 10 years, we've decoded the dynamics of adult stem cells, optimized organoid culture conditions, established a vast biobank of patient-derived organoids spanning various diseases and tissue types, and introduced groundbreaking readouts and assays revealing the complex interactions between tumors and the immune system.
In honor of the extraordinary breakthroughs that have played a pivotal role in closing the gap between the lab and the clinic, we extend a warm invitation to partake in our festivities commemorating this revolutionary decade.
Join us in the celebrations now!
An impressive array of scientific insights
ON DEMAND WEBINAR
10 years of breakthroughs in Organoid Technology: from adult stem cell discovery to changing patients’ lives
6th September 2023 | ONLINE
watch nowExplore our journey so far
2009
First organoid generated from mouse intestine
2011
First human organoid developed from intestinal epithelium
2013
Hubrecht Organoid Technology Foundation was established to upscale and commercialize organoid technology
2015
First cystic fibrosis patient treated based on organoid data
2017
HIT-CF validation trial launched
2018
First oncology clinical candidate entirely developed using organoid screening approved for clinical trials
2022
Expansion of lab facilities
2023
Hubrecht Organoid Technology becomes HUB Organoids B.V.
Dive deeper into organoid technology
ORGANOID TECHNOLOGY
Single Lgr5 stem cell build crypt-villus structures in vitro without a mescenchymal niche
Nature | May 2009
ONCOLOGY
First clinical candidate developed using HUB Organoids in five years
Case study
ORGANOID TECHNOLOGY
The FDA Modernization Act 2.0: A patient-centric paradigm shift in drug development
Blog